Proton therapy for head and neck cancer therapy: A real-world data case study from Bulgaria
Head and neck cancers (HNC) are one of the most severe types of cancer in Europe, accounting for almost 4.5% of all cancer types, according to GLOBOCAN. The incidence is geographically variable, with higher rates observed in Eastern and Southern Europe than in Northern and Western Europe. Proton and...
| Published in: | Pharmacia |
|---|---|
| Main Authors: | Maria Dimitrova, Nezabravka Tsvetanova, Daniel Penchev, Guenka Petrova |
| Format: | Article |
| Language: | English |
| Published: |
Pensoft Publishers
2024-07-01
|
| Online Access: | https://pharmacia.pensoft.net/article/129379/download/pdf/ |
Similar Items
A Real-World Study of Electronic Prescriptions and Medication Adherence in Bulgaria
by: Nikol Georgieva, et al.
Published: (2025-09-01)
by: Nikol Georgieva, et al.
Published: (2025-09-01)
Treatment patterns, adherence to international guidelines, and financial mechanisms of the market access of advanced breast cancer therapy in Bulgaria
by: Stephanie Karanyotova, et al.
Published: (2023-03-01)
by: Stephanie Karanyotova, et al.
Published: (2023-03-01)
Methodologies to Increase the Level of Evidence of Real-life Proton Therapy in Head and Neck Tumors
by: Francesco Dionisi, MD, et al.
Published: (2021-06-01)
by: Francesco Dionisi, MD, et al.
Published: (2021-06-01)
Economic consequences of the implementation of primary DNA-HPV genotype testing in Bulgaria
by: Maria Dimitrova, et al.
Published: (2024-12-01)
by: Maria Dimitrova, et al.
Published: (2024-12-01)
Clinical Review of Proton Therapy in the Treatment of Unilateral Head and Neck Cancers
by: Robert H. Press, MD, et al.
Published: (2021-06-01)
by: Robert H. Press, MD, et al.
Published: (2021-06-01)
Financial Toxicity in Head and Neck Cancer Patients Treated With Proton Therapy
by: Grace L. Smith, MD, PhD, MPH, et al.
Published: (2021-06-01)
by: Grace L. Smith, MD, PhD, MPH, et al.
Published: (2021-06-01)
Real-life study of the cost-effectiveness of benralizumab vs previous care in Bulgaria
by: Konstantin Tachkov, et al.
Published: (2025-07-01)
by: Konstantin Tachkov, et al.
Published: (2025-07-01)
Proton Therapy Outcomes for Head and Neck Cutaneous Melanoma: Proton Collaborative Group Analysis
by: James E. Han, MD, et al.
Published: (2022-07-01)
by: James E. Han, MD, et al.
Published: (2022-07-01)
Adjuvant Reirradiation With Proton Therapy in Head and Neck Squamous Cell Carcinoma
by: Kristin Hsieh, MD, et al.
Published: (2024-04-01)
by: Kristin Hsieh, MD, et al.
Published: (2024-04-01)
Synthetic computed tomography techniques for adaptive proton therapy in head and neck cancers
by: Suryakant Kaushik, et al.
Published: (2025-10-01)
by: Suryakant Kaushik, et al.
Published: (2025-10-01)
National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer
by: Johannes A. Langendijk, MD, PhD, et al.
Published: (2021-06-01)
by: Johannes A. Langendijk, MD, PhD, et al.
Published: (2021-06-01)
Digital health in Bulgaria: Imagination or possible reality?
by: Maria Dimitrova, et al.
Published: (2023-08-01)
by: Maria Dimitrova, et al.
Published: (2023-08-01)
Adherence to Acromegaly Treatment and Analysis of the Related Factors—A Real-World Study in Bulgaria
by: Maria Kamusheva, et al.
Published: (2023-01-01)
by: Maria Kamusheva, et al.
Published: (2023-01-01)
Photon versus Proton Therapy in the Management of Head and Neck Cancer: A Systematic Review
by: S Sowmya, et al.
Published: (2025-11-01)
by: S Sowmya, et al.
Published: (2025-11-01)
Using proton therapy to treat head and neck cancer and oral squamous cell carcinoma
by: Mohamed Imath, et al.
Published: (2024-06-01)
by: Mohamed Imath, et al.
Published: (2024-06-01)
Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience
by: G. Brandon Gunn, MD, et al.
Published: (2021-06-01)
by: G. Brandon Gunn, MD, et al.
Published: (2021-06-01)
The effectiveness of neoadjuvant chemotherapy prior to proton beam therapy for head and neck tumors
by: Alexey V. Nezvetskiy, et al.
Published: (2025-01-01)
by: Alexey V. Nezvetskiy, et al.
Published: (2025-01-01)
Study of head and neck squamous cell carcinoma transcriptome after proton therapy
by: E. D. Jumaniyazova, et al.
Published: (2024-04-01)
by: E. D. Jumaniyazova, et al.
Published: (2024-04-01)
Economic burden of vulvar, vaginal, anal, penile and head & neck cancers in Bulgaria
by: Hristina Lebanova, et al.
Published: (2024-10-01)
by: Hristina Lebanova, et al.
Published: (2024-10-01)
Pharmacotherapeutic Patterns and Patients’ Access to Pharmacotherapy for Some Rare Diseases in Bulgaria – A Pilot Comparative Study
by: Maria Kamusheva, et al.
Published: (2021-07-01)
by: Maria Kamusheva, et al.
Published: (2021-07-01)
CBCT-Based Adaptive Assessment Workflow for Intensity Modulated Proton Therapy for Head and Neck Cancer
by: De Ornelas Mariluz, PhD, et al.
Published: (2021-03-01)
by: De Ornelas Mariluz, PhD, et al.
Published: (2021-03-01)
Temporal Lobe Necrosis in Head and Neck Cancer Patients after Proton Therapy to the Skull Base
by: Sarin Kitpanit, et al.
Published: (2020-04-01)
by: Sarin Kitpanit, et al.
Published: (2020-04-01)
Pencil Beam Scanning Proton Therapy for Adolescents and Young Adults with Head and Neck Sarcomas
by: Miriam Vázquez, MD, et al.
Published: (2023-10-01)
by: Miriam Vázquez, MD, et al.
Published: (2023-10-01)
Proton Beam Therapy for Head and Neck Carcinoma of Unknown Primary: Toxicity and Quality of Life
by: Alexander D. Sherry, BS, et al.
Published: (2021-06-01)
by: Alexander D. Sherry, BS, et al.
Published: (2021-06-01)
Cost-Effectiveness Models of Proton Therapy for Head and Neck: Evaluating Quality and Methods to Date
by: Danmeng Huang, PhD, et al.
Published: (2021-06-01)
by: Danmeng Huang, PhD, et al.
Published: (2021-06-01)
A Real-World Study on Pulmonary Arterial Hypertension in Bulgaria: A Single-Center Retrospective Study From 2012 to 2022
by: Vasil Velchev, et al.
Published: (2025-01-01)
by: Vasil Velchev, et al.
Published: (2025-01-01)
Analysis Of Patients' Opinion Of Prescribed Medicines: A Questionnaire - Based Pilot Study In Bulgaria
by: Zornitsa Emilova Mitkova, et al.
Published: (2023-11-01)
by: Zornitsa Emilova Mitkova, et al.
Published: (2023-11-01)
Comparison of single and dual energy CT for stopping power determination in proton therapy of head and neck cancer
by: Vicki Trier Taasti, et al.
Published: (2018-04-01)
by: Vicki Trier Taasti, et al.
Published: (2018-04-01)
Benefit of range uncertainty reduction in robust optimisation for proton therapy of brain, head-and-neck and breast cancer patients
by: Ivanka Sojat Tarp, et al.
Published: (2024-07-01)
by: Ivanka Sojat Tarp, et al.
Published: (2024-07-01)
The Biological Basis for Enhanced Effects of Proton Radiation Therapy Relative to Photon Radiation Therapy for Head and Neck Squamous Cell Carcinoma
by: Li Wang, MD, PhD, et al.
Published: (2021-06-01)
by: Li Wang, MD, PhD, et al.
Published: (2021-06-01)
Independent validation of a dysphagia dose response model for the selection of head and neck cancer patients to proton therapy
by: Petros Kalendralis, et al.
Published: (2022-10-01)
by: Petros Kalendralis, et al.
Published: (2022-10-01)
Enhanced radiosensitivity of head and neck cancer cells to proton therapy via hyperthermia-induced homologous recombination deficiency
by: Tim Heemskerk, et al.
Published: (2025-03-01)
by: Tim Heemskerk, et al.
Published: (2025-03-01)
Dosimetric benefits of customised mouth-bite for head neck cancer patients undergoing modern proton therapy – An audit
by: Sapna Nangia, et al.
Published: (2024-09-01)
by: Sapna Nangia, et al.
Published: (2024-09-01)
Acute toxicities in proton therapy for head and neck cancer – A matched analysis of the DAHANCA 35 feasibility study
by: K. Nowicka-Matus, et al.
Published: (2024-09-01)
by: K. Nowicka-Matus, et al.
Published: (2024-09-01)
Large anatomical changes in head-and-neck cancers – A dosimetric comparison of online and offline adaptive proton therapy
by: Mislav Bobić, et al.
Published: (2023-05-01)
by: Mislav Bobić, et al.
Published: (2023-05-01)
Robust Intensity Modulated Proton Therapy (IMPT) Increases Estimated Clinical Benefit in Head and Neck Cancer Patients.
by: Lisanne V van Dijk, et al.
Published: (2016-01-01)
by: Lisanne V van Dijk, et al.
Published: (2016-01-01)
Quantifying the Dosimetric Impact of Proton Range Uncertainties on RBE-Weighted Dose Distributions in Intensity-Modulated Proton Therapy for Bilateral Head and Neck Cancer
by: Suresh Rana, et al.
Published: (2024-06-01)
by: Suresh Rana, et al.
Published: (2024-06-01)
Proton beam therapy in repeat irradiation of recurrent head and neck tumors: analysis of short-term results
by: D. I. Smyk, et al.
Published: (2023-03-01)
by: D. I. Smyk, et al.
Published: (2023-03-01)
Long-term nutrition therapy leads to survival benefit in head and neck cancer patients receiving targeted or immunotherapy. A retrospective cohort study with real-world data
by: Barbara Belak, et al.
Published: (2025-11-01)
by: Barbara Belak, et al.
Published: (2025-11-01)
Short-course pembrolizumab and continuous afatinib therapy for recurrent or metastatic head and neck squamous cell carcinoma: a real-world data analysis
by: Hsiang-Fong Kao, et al.
Published: (2022-11-01)
by: Hsiang-Fong Kao, et al.
Published: (2022-11-01)
Similar Items
-
A Real-World Study of Electronic Prescriptions and Medication Adherence in Bulgaria
by: Nikol Georgieva, et al.
Published: (2025-09-01) -
Treatment patterns, adherence to international guidelines, and financial mechanisms of the market access of advanced breast cancer therapy in Bulgaria
by: Stephanie Karanyotova, et al.
Published: (2023-03-01) -
Methodologies to Increase the Level of Evidence of Real-life Proton Therapy in Head and Neck Tumors
by: Francesco Dionisi, MD, et al.
Published: (2021-06-01) -
Economic consequences of the implementation of primary DNA-HPV genotype testing in Bulgaria
by: Maria Dimitrova, et al.
Published: (2024-12-01) -
Clinical Review of Proton Therapy in the Treatment of Unilateral Head and Neck Cancers
by: Robert H. Press, MD, et al.
Published: (2021-06-01)
